Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population W Tassaneeyakul, N Prabmeechai, C Sukasem, T Kongpan, P Konyoung, ... Pharmacogenetics and genomics 26 (5), 225-234, 2016 | 120 | 2016 |
Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B* 13: 01 allele in the Thai population T Tempark, P Satapornpong, P Rerknimitr, N Nakkam, N Saksit, ... Pharmacogenetics and Genomics 27 (12), 429-437, 2017 | 102 | 2017 |
Association between HLA‐B alleles and carbamazepine‐induced maculopapular exanthema and severe cutaneous reactions in Thai patients C Sukasem, C Chaichan, T Nakkrut, P Satapornpong, K Jaruthamsophon, ... Journal of immunology research 2018 (1), 2780272, 2018 | 88 | 2018 |
HLA-B*58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand C Sukasem, T Jantararoungtong, P Kuntawong, A Puangpetch, ... Frontiers in pharmacology 7, 186, 2016 | 75 | 2016 |
Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population N Koomdee, J Pratoomwun, T Jantararoungtong, V Theeramoke, ... Frontiers in pharmacology 8, 879, 2017 | 59 | 2017 |
Genetic Diversity of HLA Class I and Class II Alleles in Thai Populations: Contribution to Genotype-Guided Therapeutics P Satapornpong, P Jinda, T Jantararoungtong, N Koomdee, C Chaichan, ... Frontiers in pharmacology 11, 78, 2020 | 57 | 2020 |
A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine C Kloypan, N Koomdee, P Satapornpong, T Tempark, M Biswas, ... Pharmaceuticals 14 (11), 1077, 2021 | 53 | 2021 |
Genetic association of co‐trimoxazole‐induced severe cutaneous adverse reactions is phenotype‐specific: HLA class I genotypes and haplotypes C Sukasem, J Pratoomwun, P Satapornpong, J Klaewsongkram, ... Clinical Pharmacology & Therapeutics 108 (5), 1078-1089, 2020 | 42 | 2020 |
HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients P Satapornpong, J Pratoomwun, P Rerknimitr, J Klaewsongkram, ... Frontiers in immunology 12, 661135, 2021 | 37 | 2021 |
Drug-induced severe cutaneous adverse reactions: insights into clinical presentation, immunopathogenesis, diagnostic methods, treatment, and pharmacogenomics T Tempark, S John, P Rerknimitr, P Satapornpong, C Sukasem Frontiers in Pharmacology 13, 832048, 2022 | 34 | 2022 |
Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis C Sukasem, S Sririttha, C Chaichan, T Nakkrut, P Satapornpong, ... The Pharmacogenomics Journal 21 (6), 682-690, 2021 | 22 | 2021 |
Genetic diversity of HLA class I and class II alleles in Thai populations: Contribution to genotype-guided therapeutics. Front Pharmacol 11: 78 P Satapornpong, P Jinda, T Jantararoungtong, N Koomdee, C Chaichan, ... Alena Soha et al, 2020 | 6 | 2020 |
Effects of polymorphisms in the MTHFR gene on 5-FU hematological toxicity and efficacy in Thai colorectal cancer patients C Atasilp, R Lenavat, N Vanwong, P Chansriwong, E Sirachainan, ... Frontiers in Oncology 12, 916650, 2022 | 4 | 2022 |
Genotypic and phenotypic characteristics of co-trimoxazole-induced cutaneous adverse reactions W Iamsumang, K Chanprapaph, C Sukasem, P Satapornpong, ... Dermatology 239 (6), 966-975, 2023 | 3 | 2023 |
Influence of DPYD gene polymorphisms on 5-Fluorouracil toxicities in Thai colorectal cancer patients C Atasilp, N Vanwong, P Yodwongjane, P Chansriwong, E Sirachainan, ... Cancer Chemotherapy and Pharmacology 95 (1), 1-11, 2025 | | 2025 |
The Diversity of CYP2C19 Polymorphisms in the Thai Population: Implications for Precision Medicine V Nakhonsri, S John, H Panumasmontol, M Jantorn, P Chanthot, ... The Application of Clinical Genetics, 95-105, 2024 | | 2024 |
Impact of combined plant extracts on long COVID: An exploratory randomized controlled trial T Lukkunaprasit, P Satapornpong, P Kulchanawichien, A Prawang, ... Complementary Therapies in Medicine 87, 103107, 2024 | | 2024 |
Impact of gene polymorphisms involved in the vitamin D metabolic pathway on the susceptibility to and severity of autism spectrum disorder C Saechua, T Sarachana, W Chonchaiya, P Trairatvorakul, W Yuwattana, ... Scientific Reports 14 (1), 28333, 2024 | | 2024 |
Advances in Clinical Pharmacogenomics and Prevention of Severe Cutaneous Adverse Drug Reactions in the Era of Precision Medicine P Satapornpong, L Vorasatit, S John IntechOpen, 2024 | | 2024 |
Influence of pharmacogenomic polymorphisms on allopurinol-induced cutaneous adverse drug reactions in Thai patients G Sornsamdang, P Satapornpong, P Jinda, T Jantararoungtong, ... BMC Medical Genomics 17 (1), 101, 2024 | | 2024 |